NCT03061201 A Study of Recombinant AAV2/6 Human Factor 8 Gene Therapy SB-525 (PF-07055480) in Subjects With Severe Hemophilia A Status COMPLETED Phase PHASE2
NCT03020160 A Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Emicizumab Given Every 4 Weeks in Participants With Hemophilia A Status COMPLETED Phase PHASE3
NCT03006965 Pharmacokinetic Characterization of the Hemophilia A Population in Spain Using myPKFiT® Status COMPLETED Phase N/A
NCT02976753 Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products Status COMPLETED Phase N/A
NCT02971930 Exit Interviews to Assess Impact of Infusion Frequency in Hemophilia A Status COMPLETED Phase N/A
NCT02962765 Non-interventional Post-authorisation Study to Document the Immunogenicity, Safety, and Efficacy of NUWIQ Status COMPLETED Phase N/A
NCT02930317 Evaluate Efficacy and Safety of Recombinant Factor VIII (rFVIII)Treatment of Severe or Moderately Severe Hemophilia A Status UNKNOWN Phase PHASE3
NCT02921945 Efficacy and Safety Study of SCT800 for On-demand Treatment With in Patients With Hemophilia A Status UNKNOWN Phase PHASE3
NCT02911233 Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity Status COMPLETED Phase N/A
NCT02888223 Pharmacokinetic Study of SCT800 in Previously Treated Patients With Hemophilia A Status UNKNOWN Phase PHASE1
NCT02851082 Could Physical Activity Help to Counteract the Blood Haemophilia Disturbance? A Pilot Study. Status COMPLETED Phase NA
NCT02847637 A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors Status COMPLETED Phase PHASE3
NCT02795767 A Study of Emicizumab Administered Subcutaneously (SC) in Pediatric Participants With Hemophilia A and Factor VIII (FVIII) Inhibitors Status COMPLETED Phase PHASE3